Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Department of Health and Human Services · Centers for Disease Control and Prevention · CDC OFFICE OF ACQUISITION SERVICES
Account requiredWhy it scored this way
Every reason behind the verdict rather than the headline one — which of your certifications match, how much runway is left, whether the work is your size, and what we would need to know to sharpen it.
Written against this notice and what you have told us about your company. Anything we do not know is marked [NEEDS INPUT] in the draft rather than guessed at — read it before you send it.
Start a free trial to draft these. Nothing is sent to an agency on your behalf, ever — you get a document to review, edit and submit yourself.
Compliance matrix
Every stated and implied requirement, its source section, whether it is mandatory, and where your response will address it.
Proposal outline
A submission skeleton where every required element is a heading with its source requirement quoted beneath it. You write the substance; nothing gets forgotten.
Questions to submit
Genuine ambiguities and requirements that disadvantage a smaller bidder, drafted as questions you can submit before the Q&A deadline.
Past performance write-ups
Which of your prior awards best match this requirement, and draft write-ups in the format the agency asked for.
Solicitation details
Solicitation number
97469
Notice type
Combined Synopsis/Solicitation
NAICS
541715
Product service code
AN11
Set-aside
Unrestricted
Posted
2026-08-17
Response deadline
Aug 26, 2026, 2:00 PM UTC
Place of performance
Atlanta, GA
Contracting contact
qsx8@cdc.gov
Market intelligence
Account requiredWho wins this work, and what it pays
Comparable awards under NAICS 541715 at this agency — the incumbent, what they were paid, when their period of performance ends, and the real pricing distribution rather than the headline number. From public federal award records.
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued. The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order. Description of Requirement The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses: Human West Nile virus (WNV) vaccine Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW). Product or Service Code: AN11 – Health R&D Services, Epidemiology NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences Period of Performance: September 30, 2026 – September 29, 2027 (12 months). Delivery Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required. Submission Requirements Offerors shall submit the following: Completed pricing for all CLINs. A Time-and-Materials quotation for the entire period of performance. Written acknowledgement of the Statement of Work confirming the ability to perform the required services. Active System for Award Management (SAM) registration, including UEI, with no active exclusions. Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.
Contact
Point of contact
Iris Gonzalez
Role
not stated on this notice — SAM publishes a role for only about 5% of them, so this may be a contract specialist rather than the contracting officer
Email
qsx8@cdc.gov
Submit questions
Ambiguities and requirements worth clarifying, written as questions you can send before the deadline.
Opens in your own mail client, addressed and with a subject line — you write the message. GovSprint never sends anything on your behalf.
Emails open in your mail client and are sent from your address, so the reply comes back to you and the exchange stays yours. Confirm the correct channel and any question deadline on the notice before sending — many solicitations require questions in a specific way.
